The present study shows that there is increased CD83 expression in fibroadenomas, compared with the adjacent breast tissue (P < 0.001), and this could represent more intense immune activity against these benign tumors, probably mediated by antigen-presenting cells (APC). The gene discussed is CD83; the disease is Fibroadenoma.